|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3954690 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21182842.1 |
| Date of filing the European patent application | 2016-07-01 | |
| (97) | Date of publication of the European application | 2022-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation | 2023-05-25 |
| (30) | Number | Date | Country code |
| 201562188468 P | 2015-07-02 | US | |
| 201562271708 P | 2015-12-28 | US |
| (72) |
BLATTER, Fritz , CH
INGALLINERA, Tim , US
BARF, Tjeerd , NL
ARET, Edwin , NL
KREJSA, Cecile , US
EVARTS, Jerry , US
|
| (73) |
Acerta Pharma B.V. ,
Kloosterstraat 9, 5349 AB Oss,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | (S)-4-(8-Amino-3-(1-(but-2-inoil)pirolidin-2-il)imidazo[1,5-A] pirazin-1-il)-N-(piridin-2-il)benzamido kompozicijų kietosios formos |
| SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE |
| Payment date | Validity (years) | Amount | |
| 2024-07-02 | 9 | 312.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-02-13 |